Age-related Cognitive Change of Femur

NCT ID: NCT02220322

Last Updated: 2016-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Age-related change of femur is not well-known. The investigators investigated the longitudinal changes of femur.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recently, bisphosphonate-related atypical fracture of femur (AFF) is paid attention in clinicians. Almost all AFFs were occurred in thicker cortical thickness. But age-related change of femur is not well-known.

The main objective of this study is to reveal the age-related change of femur.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Osteoporosis or osteopenia patients who presented to our hospital

Exclusion Criteria

* Patients without osteoporosis or osteopenia
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tomidahama Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Toshihiko Kono

Head of Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rui Niimi, PhD

Role: PRINCIPAL_INVESTIGATOR

Tomidahama Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tomidahama Hospital

Yokkaichi, Mie-ken, Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rui Niimi, MD, PhD

Role: CONTACT

(81)-59-365-0023

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rui Niimi, MD, PhD

Role: primary

(81)-59-365-0023

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB TH No 9

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resting-state Imaging and OSteoporosiS
NCT07030205 NOT_YET_RECRUITING NA
Osteoporosis After Stroke
NCT07059468 NOT_YET_RECRUITING